ANIP 61.05 (+1.65%)
US00182C1036Drug ManufacturersDrug Manufacturers - Specialty & Generic

ANI Pharmaceuticals (ANIP) Competitor Comparison

We are evaluating the key criteria listed to compare ANI Pharmaceuticals (ANIP) against its competitors in the Drug Manufacturers - Specialty & Generic industry.

Linearity 3 years - ANIP ranking 32 / 54

These are the competitors of ANI Pharmaceuticals in the industry Drug Manufacturers - Specialty & Generic ranked by linearity 3 years
1. Kamada KMDA
115.79
2. Phibro Animal Health PAHC
94.64
3. Zoetis ZTS
49.57
4. Alvotech ALVO
18.17
5. Supernus Pharmaceuticals SUPN
15.53
6. Kolinpharma KIP.MI
11.59
7. Alimera Sciences ALIM
11.3
8. ProPhase Labs PRPH
6.36
9. Vifor Pharma G2AB.F
6.24
10. Perrigo PRGO
5.35
11. PetIQ PETQ
5.2
12. Cumberland Pharmaceuticals CPIX
3.94
13. Taro Pharmaceutical Industries TARO
3.87
14. Regencell Bioscience Holdings RGC
3.86
15. Ironwood Pharmaceuticals IRWD
3.71
16. Linc LNC
3.12
17. Pacira BioSciences PCRX
3.04
18. Zynerba Pharmaceuticals ZYNE
3
19. Elanco Animal Health ELAN
2.91
20. Catalent CTLT
2.9
21. Green Thumb Industries R9U2.F
2.71
22. Embecta EMBC
2.68
23. Avadel Pharmaceuticals AVDL
2.64
24. Journey Medical DERM
2.55
25. OptiNose OPTN
2.55
26. Cronos Group CRON
2.48
27. Societal CDMO SCTL
2.41
28. Procaps Group PROC
2.34
29. Curaleaf Holdings CURLF
2.25
30. SCYNEXIS SCYX
2.22
31. Eagle Pharmaceuticals EGRX
2.19
32. ANI Pharmaceuticals ANIP
2.18
33. Bausch Health Companies BHC
2.1
34. Relmada Therapeutics RLMD
1.88
35. Theratechnologies THTX
1.87
36. Jupiter Wellness JUPW
1.84
37. Collegium Pharmaceutical COLL
1.78
38. Ascend Wellness Holdings AAWH
1.76
39. Emergent BioSolutions EBS
1.75
40. Universe Pharmaceuticals UPC
1.74
41. Flora Growth FLGC
1.74
42. Tilray Brands TLRY
1.72
43. Alpha Teknova TKNO
1.7
44. Biofrontera BFRI
1.68
45. Organogenesis Holdings ORGO
1.66
46. Solid Biosciences SLDB
1.62
47. Amphastar Pharmaceuticals AMPH
1.61
48. Neoleukin Therapeutics NLTX
1.57
49. Ayr Wellness 3KJB.F
1.54
50. Clever Leaves Holdings CLVR
1.47
51. Amneal Pharmaceuticals AMRX
1.36
52. Teva Pharmaceutical Industries TEVA
1.22
53. Evolus EOLS
1.16
54. Harrow Health HROW
0.38

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.